Meeting
2019 Gastrointestinal Cancers Symposium
Proteomic analysis to identify markers for response to treatment in esophageal cancer.
Authors
Oran Zlotnik
Rabin Medical Center, Petah-Tikva, Israel
Oran Zlotnik , Tal Goshen-Lago , Baruch Brenner , Yulia Kundel , Nikolai Menasherov , Hanoch Kashtan , Irit Ben-Aharon
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Translational Research
Citation
J Clin Oncol 37, 2019 (suppl 4; abstr 61)
DOI
10.1200/JCO.2019.37.4_suppl.61
Abstract #
61
Poster Bd #
G11
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
Impact of pathological response and recurrence pattern on the survival of patients who develop recurrence from neoadjuvant chemoradiotherapy for locally advanced esophageal squamous cell carcinoma (ESCC).
First Author: Chien Huai Chuang
Poster
2018 ASCO Annual Meeting
Induction chemoradiotherapy for esophageal cancer: Comparing CROSS regimen with cisplatin/5-FU.
First Author: Abraham Geller
Poster
2017 Gastrointestinal Cancers Symposium
Association between markers of malnutrition (MN) and toxicity (T) during neoadjuvant chemoradiotherapy (nCRT) for esophageal cancer (EC).
First Author: Rishi Jain
Poster
2016 Gastrointestinal Cancers Symposium
Efficacy and feasibility of neoadjuvant chemotherapy and chemoradiotherapy for elderly patients with stage IB/II/III (excluding T4) esophageal cancer: Retrospective study.
First Author: Takahiro Miyamoto